Patent ID: 11944678
Assignee: ENDING PATIENT ZERO, LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  G  C | IPC A  C

Claim 0:
1. A transmission system for targeted mass inoculation, comprising:
a first at least one pathogen;
at least one host, wherein the first at least one pathogen is administered to the at least one host via external administration, and wherein the at least one host comprises the first at least one pathogen;
a second at least one pathogen;
at least one vector, wherein the at least one vector is introduced to the at least one host at a first location, wherein the second at least one pathogen is receivable from the at least one host by the at least one vector, and wherein the at least one vector comprises the second at least one pathogen;
at least one secondary host, wherein the second at least one pathogen is receivable from the at least one vector by the at least one secondary host when the at least one vector is introduced to the at least one secondary host at a second location.